Children have yet to be involved in any clinical trials for a COVID-19 vaccine, meaning they may have to wait significantly longer than the rest of the population to be inoculated, according to Business Insider.

The FDA is requiring the warning information be updated for benzodiazepines, a class of common psychiatric drugs used to treat generalized anxiety disorder, seizures, insomnia, social phobia and panic disorder.

A majority of community pharmacies have lost patients in the last six months due to unfair patient steering, and CVS Health is most often the culprit, the National Community Pharmacists Association claims. 

Gilead agreed to pay a $97 million settlement for allegations it used a charity to pay illegal kickbacks to Medicare patients to cover copays for its high blood pressure drug Letairis.

HHS General Counsel Robert Charrow scolded Eli Lilly in a Sept. 21 letter for its recent actions to halt 340B discounts to hospitals. 

The FDA has issued a proposed rule that clarifies when drugmakers are required to update their drug labels to reflect off-label use, STAT reported. 

Swiss pharma giant Novartis recently garnered about $2.1 billion from investors by selling bonds linked to its promises to make its treatments more accessible in lower-income countries, according to STAT.

The FDA is expected to announce new standards for emergency use authorization of a COVID-19 vaccine as soon as this week, which would make it more difficult for any vaccine to be approved before Election Day, The Washington Post reported. 

HHS has shifted billions of dollars from public health programs to Operation Warp Speed, with $6 billion pulled from the Strategic National Stockpile, Bloomberg reported. 

Johnson & Johnson launched the phase 3 trial for its experimental COVID-19 vaccine Sept. 23, testing the single-shot candidate's effectiveness in preventing COVID-19 against a placebo.

OptumRx, the pharmacy benefit unit of UnitedHealth Group, recently released a report detailing three drugs that it expects to have a significant impact on the pharmaceutical industry in 2020. 

Medicare won't cover the cost of a COVID-19 vaccine if it is approved under an emergency use authorization, according to The Wall Street Journal. 

The pharmacy department is uniquely positioned to help hospitals and health systems improve patient outcomes, safety and financial performance, making pharmacists and pharmacy leaders well-equipped to help the organization succeed. 

Pharmacy leaders from hospitals across the nation are using what they've learned during the COVID-19 pandemic to develop pandemic preparedness models. 

West Virginia pharmacist Natalie Cochran, PharmD, pleaded guilty to one count of wire fraud and one count of money laundering, U.S. Attorney Mike Stuart announced Sept. 21.

Halifax Health Medical Center in Daytona Beach, Fla., opened a new in-hospital Publix Pharmacy Sept. 21.

Ten hospitals and health systems posted job listings seeking pharmacy leaders in the last week.

A group of Black physicians has created its own task force to independently vet regulators' decisions regarding COVID-19 drugs and vaccines in an attempt to safeguard against any potential political influence in federal health agencies, STAT reported. 

AstraZeneca published its COVID-19 vaccine clinical trial protocol Sept. 19, shortly after Moderna and Pfizer both released their protocols, The New York Times reported. The three drugmakers are the furthest along in clinical trials for a COVID-19 vaccine. 

Moncef Slaoui, PhD, chief adviser of Operation Warp Speed, the White House's task force to develop a COVID-19 vaccine, said during a Sept. 21 CNBC interview that Americans "most susceptible" to the disease could be immunized by December if the FDA approves a vaccine before then.